rolxin 40/320 40 mg + 320 mg oral solid ordinary film-coated tablets
raine industries - dihydroartemisinin + piperaquine phosphate - oral solid ordinary film-coated tablets - 40 mg + 320 mg
rolxin 90/720 (90 mg + 720 mg)/60 ml oral liquid ordinary dry suspensions/syrups/drops
raine industries - dihydroartemisinin + piperaquine phosphate - oral liquid ordinary dry suspensions/syrups/drops - (90 mg + 720 mg)/60 ml
artequick tablets film-coated tablet
artepharm co. ltd. china fengshun economic and technological development - artemisinin and piperaquine tablets - film-coated tablet - artemisinin (c15h22o5) - antimalarial antiprotozoals: aminoquinolines
co-malasinin tablets coated tablet
dawa limited p.o. box 16633-00620 nairobi, kenya - dihydroartemisin & piperaquine phosphate - coated tablet - dihydroartemisin 40mg & piperaquinine phosphate - antimalarial antiprotozoals: combinations of
duomal tablet
zawadi healthcare ltd po box 14629 - 00800 nairobi. kenya - dihydroartemisinin + piperaquine phosphate - tablet - 40 mg + 320 mg - antimalarial antiprotozoals: combinations of
ridmal 40/320 tablet
ajanta pharma ltd ajanta pharma ltd, ajanta house,chakop, kandivli - dihydroartemesinin and piperaquine phosphate - tablet - each film coated tablet - antimalarial antiprotozoals: combinations of
synriam dt dispersible tablet
sun pharmaceutical industries limited sun house, plot no. 201 b/1 western express - arterolane maleate and piperaquine phosphate - dispersible tablet - each uncoated tablet contains: arterolane maleate - other antimalarial antiprotozoals
synriam dt 37.5 mg + 187.5 mg oral solid ordinary tablets
sun pharmaceutical industries limited - - arterolane maleate + piperaquine phosphate - oral solid ordinary tablets - 37.5 mg + 187.5 mg
p-alaxin 20 mg + 160 mg oral solid ordinary soluble tablets
bliss gvs pharma limited - dihydroartemisinin + piperaquine phosphate - oral solid ordinary soluble tablets - 20 mg + 160 mg
deltyba
otsuka novel products gmbh - delamanid - tuberculosis, multidrug-resistant - antimycobacterials - deltyba is indicated for use as part of an appropriate combination regimen for pulmonary multi-drug resistant tuberculosis (mdr-tb) in adults, adolescents, children and infants with a body weight of at least 10 kg when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability (see sections 4.2, 4.4 and 5.1).consideration should be given to official guidance on the appropriate use of antibacterial agents.